[A study of serum levels of cefoperazone sodium and its movement to myocardial tissue].
After introduction of anesthesia to 19 patients requiring cardiac surgery, cefoperazone sodium (CPZ) 1 g was administered intravenously and its movement to serum, pericardial fluid and tissue of the right auricle was studied. The serum CPZ level was 75.68 micrograms/ml and 59.77 micrograms/ml at 60 and 120 minutes after administration, respectively, and the biological half-life time was 2.54 hours. Lengths of time to achieve peak concentrations of CPZ in pericardial fluid and right auricle tissue after administration were both approximately 1 hour. The drug level in myocardial tissue was 14.52 micrograms/g after 240 minutes. Level of CPZ in myocardial tissue was maintained, even after 240 minutes, sufficiently higher than MIC80 of the drug against Gram-negative bacilli which may be responsible for many infections. No side effects were observed in any case examined.
D000328:Adult; D006348:Cardiac Surgical Procedures; D002438:Cefoperazone / Q000097:blood* / Q000627:therapeutic use; D005260:Female; D006330:Heart Defects, Congenital / Q000378:metabolism / Q000601:surgery; D006331:Heart Diseases / Q000378:metabolism / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication
D002438:Cefoperazone